Sebastian Rosch

Cardiology | Hemodynamics | Pressure-Volume Loops | Tricuspid Regurgitation | Zentrum für Kardiologie der Universitätsmedizin Mainz

[Philipp Lurz @PhilippLurz]

World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group
@vonBardelebenRS @AGIKinterv @DGK_org @EZancanaroMD @KardiologieHH @ESC_Journals @thiele_holger

[Franziska Koppe-Schmeißer @Franzi_Koppe]

Tolle Vorträge aus Mainz bei der Young-Investigator-Award Session zum Thema Herzinsuffizienz 🫀 @KP_Kresoja @RoschSeb @felix_mller @YoungDgk @DGK_org

[Dmitry Sulimov @sulimov_dmitry]

Very dramatic case of dry tamponade: terrible complication
https://t.co/FG2APPMoUD
@TobiasKister @thiele_holger

[JACC Journals @JACCJournals]

T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 https://t.co/Z2iWRlNKtn

#TEER #Cardiology #vhdTR @PhilippLurz

[Cardiovascular Research Foundation @crfheart]

🔥 #THT2025 is in full swing! The room is packed with attendees diving into the latest breakthroughs in #heartfailure research and treatments. Exciting sessions, cutting-edge insights — this is where #innovation happens! 🫀🚀

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @djc795 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @navinkapur4 @dranulala @MartyBLeon @LindenfeldJoann @PopmaJeffrey @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @ISHLT @HFSA

[Karl-Philipp Rommel @kp_rommel]

🚨 #HFpEF remains biggest unmet need in CV medicine!

❓Can #InterventionalHF + #ShuntTherapy live up to the promise?

⚡RA "vortex" flow might be 🔑 to understanding #RightHeartfailure with shunting!

👀intriguing narrative and stunning MRI visuals by @HEARTinMagnet below👇

[Joseph Marine @DrJMarine]

Enjoying a great day hosting #FITs from ⁦@DGK_org⁩ at ⁦@hopkinsheart⁩ as part of ⁦@ACCMaryland⁩ exchange program. We have much to learn from each other in advancing cardiac care! @sxz110⁩ ⁦@HadleyWilsonMD⁩ ⁦@CathieBiga⁩ ⁦@ACCinTouch⁩

[Joseph Marine @DrJMarine]

Wonderful to celebrate the 15th anniversary of MACCS in DC and welcome our first contingent of German cardiology fellows for ⁦@DGK_org⁩ - ⁦@ACCMaryland⁩ exchange! Main event tomorrow! ⁦@ACCinTouch⁩ ⁦@HadleyWilsonMD⁩ ⁦@CathieBiga⁩ ⁦@sxz110⁩

[Philipp Lurz @PhilippLurz]

supranormal ejection fraction HFpEF different entity with distinct pathophysiology and afterload and systolic stiffness/hypercontractility as disease drivers rather than fibrosis, just at the beginning here…

[Karl-Patrik Kresoja @KP_Kresoja]

🔥#FINEARTS a win for #HFpEF
- Reduction in HFH 🏨 and trend for ☠️ ⬇️
- Yet again, no signal in HFpEF&LVEF >60%
- what's the deal with those ef>60% and high NT-proBNP level guys anyway?
@PhilippLurz @thiele_holger @vonBardelebenRS @KardiologieHH @MarcoMetra @kp_rommel #ESC2024

[Marat Fudim, MD MHS @FudimMarat]

Finerenone meets primary endpoint in Phase III FINEARTS-HF🎉
❤️ expanded treatment options for HFpEF! —> to be presented at ESC

‼️pending: the SPIRRT HFPEF trial with MRA

⁦@DCRINews⁩ ⁦@karolinskainst⁩ ⁦@UU_University⁩ ⁦@nih_nhlbi⁩ https://t.co/FjfWQo6KqR

[Karl-Philipp Rommel @kp_rommel]

⁉️FIM = First in @UnimedizinMainz ‼️ Use of the Paradise® Ultrasound #RenalDenervation System! 👀 forward to establish a role in management of #Hypertension and #heartfailure @ReCorMedical @PhilippLurz @FudimMarat @KP_Kresoja @guilbon

[Karl-Patrik Kresoja @KP_Kresoja]

Why does treating #TR improve dyspnoea? Find out more on the importance and effects of #TTEER on left 🫀 #hemodynamics and #HeartFailure

https://t.co/zgKQx2Lxod

@kp_rommel @PhilippLurz @thiele_holger @A_Schoeber @RoschSeb @PSullivan000 @MarcoMetra @FH_Verbrugge

a 🧵1/6

[Franziska Koppe-Schmeißer @Franzi_Koppe]

Alles rund um HFpEF - spannende Sitzung des Tagunspräsidenten mit @PhilippLurz bei der #DGK2024JT @kp_rommel @KP_Kresoja @RoschSeb @DGK_org @youngdgk @docduc88 @docrogmarc @felix_mller @PhilipWenzel_76

[Karl-Philipp Rommel @kp_rommel]

🔥#hemodynamics for 🧑‍🤝‍🧑 selection #TTEER + right #HeartFailure🔥

Join us for great session 9.30 today PB17 #DGKJahrestagung and check out SimPub in #EJHF

@PhilippLurz @thiele_holger @sarabombace @stolz_l @j_hausleiter @KP_Kresoja @guilbon @KardiologieHH #PCRtricuspid

[Karl-Philipp Rommel @kp_rommel]

🔥#TTEER improves left 🫀 #hemodynamics and #HeartFailure ‼️

Check out elegant #PVLoop analysis by @KP_Kresoja @PhilippLurz @RoschSeb @mvonroeder @sarabombace @A_Schoeber @AGIKinterv @YoungDgk

Today @ YIA Session #DGKJahrestagung , SimPub in #EJHF : https://t.co/fvfM0MVbzu

[Karl-Philipp Rommel @kp_rommel]

#HFpEF is hard to👊!?

Here we discuss potential pathophysiology-guided interventional 🎯.

🙏 @RoschSeb #KarlFengler @KP_Kresoja @tommasoggori @thiele_holger @PhilippLurz @BurkhoffMd and #EricStöhr

#HeartFailure #InterventionalHeartFailure

[Philipp Lurz @PhilippLurz]

Worldwide first commercial #EVOQUE case today at @unimedizinMainz and #HeartValveCenter closing the loop from interventional innovation to clinical reality, result of robust science and a fantastic newly assembled heart team.
@vonBardelebenRS, H. Treede, T. Goessler, Tobias Ruf

[Karl-Philipp Rommel @kp_rommel]

Can we👊 large artey stiffness in #HFPEF ❓

Shortly before the start of #TCT2023 our article in @CircHF now explores an innovative interventional #HeartFailure treatment using #RenalDenervation: https://t.co/IL7g5BsLLL

Thanks to @PhilippLurz @BurkhoffMd @KP_Kresoja #KarlFengler